Yang Xiangjun, Hondur Gözde, Li Ming, Cai Jian, Klein Jon B, Kuehn Markus H, Tezel Gülgün
Department of Ophthalmology Columbia University College of Physicians and Surgeons, New York, New York, United States.
Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky, United States.
Invest Ophthalmol Vis Sci. 2015 Sep;56(10):5816-30. doi: 10.1167/iovs.15-17294.
To better understand ocular hypertension-induced early molecular alterations that may determine the initiation of neurodegeneration in human glaucoma, this study analyzed retinal proteomic alterations in the ocular hypertensive human retina.
Retina samples were obtained from six human donors with ocular hypertension (without glaucomatous injury) and six age- and sex-matched normotensive controls. Retinal proteins were analyzed by two-dimensional LC-MS/MS (liquid chromatography and linear ion trap mass spectrometry) using oxygen isotope labeling for relative quantification of protein expression. Proteomics data were validated by Western blot and immunohistochemical analyses of selected proteins.
Out of over 2000 retinal proteins quantified, hundreds exhibited over 2-fold increased or decreased expression in ocular hypertensive samples relative to normotensive controls. Bioinformatics linked the proteomics datasets to various pathways important for maintenance of cellular homeostasis in the ocular hypertensive retina. Upregulated proteins included various heat shock proteins, ubiquitin proteasome pathway components, antioxidants, and DNA repair enzymes, while many proteins involved in mitochondrial oxidative phosphorylation exhibited downregulation in the ocular hypertensive retina. Despite the altered protein expression reflecting intrinsic adaptive/protective responses against mitochondrial energy failure, oxidative stress, and unfolded proteins, no alterations suggestive of an ongoing cell death process or neuroinflammation were detectable.
This study provides information about ocular hypertension-related molecular risk factors for glaucoma development. Molecular alterations detected in the ocular hypertensive human retina as opposed to previously detected alterations in human donor retinas with clinically manifest glaucoma suggest that proteome alterations determine the individual threshold to tolerate the ocular hypertension-induced tissue stress or convert to glaucomatous neurodegeneration when intrinsic adaptive/protective responses are overwhelmed.
为了更好地理解高眼压引起的早期分子改变,这些改变可能决定人类青光眼中神经变性的起始,本研究分析了高眼压患者视网膜的蛋白质组学变化。
从六名患有高眼压(无青光眼损伤)的人类供体和六名年龄及性别匹配的血压正常对照者获取视网膜样本。使用氧同位素标记对视网膜蛋白质进行二维液相色谱-串联质谱分析(液相色谱和线性离子阱质谱),以相对定量蛋白质表达。通过对选定蛋白质的蛋白质印迹和免疫组织化学分析验证蛋白质组学数据。
在定量的2000多种视网膜蛋白质中,数百种蛋白质在高眼压样本中的表达相对于血压正常对照者增加或减少了两倍以上。生物信息学将蛋白质组学数据集与高眼压视网膜中维持细胞稳态重要的各种途径联系起来。上调的蛋白质包括各种热休克蛋白、泛素蛋白酶体途径成分、抗氧化剂和DNA修复酶,而许多参与线粒体氧化磷酸化的蛋白质在高眼压视网膜中表现出下调。尽管蛋白质表达的改变反映了针对线粒体能量衰竭、氧化应激和未折叠蛋白质的内在适应性/保护性反应,但未检测到提示正在进行的细胞死亡过程或神经炎症的改变。
本研究提供了与青光眼发展相关的高眼压分子危险因素的信息。在高眼压人类视网膜中检测到的分子改变与先前在具有临床明显青光眼的人类供体视网膜中检测到的改变相反,这表明蛋白质组改变决定了个体耐受高眼压诱导的组织应激或在内在适应性/保护性反应不堪重负时转变为青光眼性神经变性的阈值。